For example, Nina Hauptman et al [13] found that CEP55 is a potential biomarker for colorectal cancer through bioinformatics methods and clinical studies; Yang Jia et al [14] found that in esophageal squamous cell carcinoma (ESCC), CEP55 overexpression is associated with poor prognosis in patients with locally advanced ESCC. Here, CEP55 is linked to esophageal squamous cell carcinoma.